DNA

#3010
Ginkgo Bioworks Holdings, Inc.
8.0100 USD
+0.63%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
7.9750
8.0100
Faixa anual
5.3700
9.7200
Mudança diária
+0.63%
Mudança mensal
+19.20%
Mudança em 6 meses
-9.80%
Mudança anual
-9.80%
Fechamento anterior
7.9600
Abrir
7.9800
Bid
Ask
Mínimo
7.9750
High
8.0100
Volume
52
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 471.9841 M
  • Employee 485
  • Founded 2008
  • CEO Jason Kelly
  • Website www.ginkgobioworks.com
  • Headquarter Delaware, United States
  • FIGI BBG00YPS1KY3
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-1.47
Índice preço/fluxo de caixa
2.71

Ginkgo Bioworks Holdings Inc Class A

Ginkgo Bioworks Holdings, Inc. is an American biotech company founded in 2008 by five scientists from MIT, headed by Jason Kelly. The company specializes in using genetic engineering to produce bacteria with industrial applications for other biotech companies, saving other companies the cost of reproducing the initial stages of design in synthetic biology. The self-proclaimed "Organism Company" was one of the world's largest privately held biotech companies, valued at $4.2 billion in 2019. It raised $290 million in September and $350 million in October of that year. Ginkgo Bioworks went public on the New York Stock Exchange via a SPAC merger on September 17, 2021.

Notícias